Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search

Cardiovascular Pharmacology

Citations 541-550 of 640 total displayed.

Past content (since Jan 1999):

Scientific Contributions
Coronary Hemodynamic and Ventricular Responses to Angiotensin Type 1 Receptor Inhibition in SHR : Interaction With Angiotensin Type 2 Receptors
Jasmina Varagic, Dinko Susic, and Edward D. Frohlich
Hypertension 2001;37:1399-1403 [Abstract] [Full text]  

Scientific Contributions
Mechanisms of Carvedilol Action in Human Congestive Heart Failure
David M. Kaye, Leonie Johnston, Gautam Vaddadi, Hanspeter Brunner-LaRocca, Garry L. Jennings, and Murray D. Esler
Hypertension 2001;37:1216-1221 [Abstract] [Full text]  

Scientific Contributions
Therapeutic Actions of a New Synthetic Vasoactive and Natriuretic Peptide, Dendroaspis Natriuretic Peptide, in Experimental Severe Congestive Heart Failure
Ondrej Lisy, John G. Lainchbury, Hanna Leskinen, and John C. Burnett, Jr
Hypertension 2001;37:1089-1094 [Abstract] [Full text]  

Scientific Contributions
Lacidipine Prevents Endothelial Dysfunction in Salt-Loaded Stroke-Prone Hypertensive Rats
Peter Krenek, Salvatore Salomone, Jan Kyselovic, Maurice Wibo, Nicole Morel, and Théophile Godfraind
Hypertension 2001;37:1124-1128 [Abstract] [Full text]  

Scientific Contributions
Effect of N-Acetyl-Seryl-Aspartyl-Lysyl-Proline on DNA and Collagen Synthesis in Rat Cardiac Fibroblasts
Nour-Eddine Rhaleb, Hongmei Peng, Pamela Harding, Mahmoud Tayeh, Margot C. LaPointe, and Oscar A. Carretero
Hypertension 2001;37:827-832 [Abstract] [Full text]  

Scientific Contributions
Epoxyeicosatrienoic Acid–Mediated Renal Vasodilation to Arachidonic Acid Is Enhanced in SHR
Silvia I. Pomposiello, Mairead A. Carroll, John R. Falck, and John C. McGiff
Hypertension 2001;37:887-893 [Abstract] [Full text]  

Scientific Contributions
Restoration of Nitric Oxide Availability After Calcium Antagonist Treatment in Essential Hypertension
Stefano Taddei, Agostino Virdis, Lorenzo Ghiadoni, Armando Magagna, Stefania Favilla, Alfonso Pompella, and Antonio Salvetti
Hypertension 2001;37:943-948 [Abstract] [Full text]  

Scientific Contributions
Effects of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Type 1 Receptor Antagonist in Deoxycorticosterone Acetate–Salt Hypertensive Mice Lacking Ren-2 Gene
Hongmei Peng, Oscar A. Carretero, Marcos E. Alfie, Julie A. Masura, and Nour-Eddine Rhaleb
Hypertension 2001;37:974-980 [Abstract] [Full text]  

Scientific Contributions
Prevention of Hypertension by Irbesartan in Dahl S Rats Relates to Central Angiotensin II Type 1 Receptor Blockade
Frans H. H. Leenen and Baoxue Yuan
Hypertension 2001;37:981-984 [Abstract] [Full text]  

Scientific Contributions
Hypothesis: ß-Adrenergic Receptor Blockers and Weight Gain : A Systematic Analysis
Arya M. Sharma, Tobias Pischon, Sandra Hardt, Iris Kunz, and Friedrich C. Luft
Hypertension 2001;37:250-254 [Abstract] [Full text]  

[First page]   [Previous page]   [Next page]
Pages: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 35 36 37 38 39 40 41 42 43 44 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64

* Subspecialty Collections Home

* Show  Cardiovascular Pharmacology
 collections from other journals.

* Related collections:
 Treatment
 Ablation/ICD/surgery
 Behavioral/psychosocial - treatment
 Cardiovascular Pharmacology
 Catheter-based coronary and valvular interventions: other
 Catheter-based coronary interventions: stents
 Compliance/Adherence
 CPR and emergency cardiac care
 Exercise/exercise testing/rehabilitation
 Pacemaker
 Primary prevention
 Restenosis
 Secondary prevention
 Other Treatment